ADIA Nutrition Inc. Identifies Historical Share Issuance Issues; Commits to Retiring over 25 Million Shares
ADIA Nutrition Inc. (OTC Pink: ADIA) has discovered issues with approximately 25 million shares issued or committed without proper documentation over a decade ago. This includes 15 million currently outstanding shares and 10 million shares promised in a payment agreement before the current board's tenure. The company plans to retire these shares, which would reduce outstanding shares by about 15%.
Current share structure shows: 95,899,861 outstanding shares, 74,051,080 restricted shares, 21,848,781 unrestricted shares, 19,575,347 shares held at DTC, and a float of 13,848,781. The company is investigating additional restricted shares that might have been improperly issued. Management is working with legal advisors to properly retire the shares while maintaining operational focus on health and wellness initiatives, including umbilical cord stem cell treatments and HSCT for Multiple Sclerosis.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha scoperto delle problematiche con circa 25 milioni di azioni emesse o promettenti senza una documentazione adeguata oltre un decennio fa. Questo include 15 milioni di azioni attualmente in circolazione e 10 milioni di azioni promesse in un accordo di pagamento prima dell'attuale mandato del consiglio. L'azienda prevede di ritirare queste azioni, il che ridurrebbe il numero di azioni in circolazione di circa il 15%.
La struttura attuale delle azioni mostra: 95.899.861 azioni in circolazione, 74.051.080 azioni ristrette, 21.848.781 azioni non ristrette, 19.575.347 azioni detenute presso il DTC, e un flottante di 13.848.781. L'azienda sta indagando su ulteriori azioni ristrette che potrebbero essere state emesse in modo inappropriato. La direzione sta collaborando con consulenti legali per ritirare correttamente le azioni mantenendo al contempo il focus operativo sulle iniziative di salute e benessere, inclusi i trattamenti con cellule staminali del cordone ombelicale e HSCT per la sclerosi multipla.
ADIA Nutrition Inc. (OTC Pink: ADIA) ha descubierto problemas con aproximadamente 25 millones de acciones emitidas o comprometidas sin la documentación adecuada hace más de una década. Esto incluye 15 millones de acciones actualmente en circulación y 10 millones de acciones prometidas en un acuerdo de pago antes del actual mandato de la junta. La empresa planea retirar estas acciones, lo que reduciría las acciones en circulación en aproximadamente un 15%.
La estructura actual de acciones muestra: 95,899,861 acciones en circulación, 74,051,080 acciones restringidas, 21,848,781 acciones no restringidas, 19,575,347 acciones mantenidas en DTC, y un flotante de 13,848,781. La empresa está investigando acciones restringidas adicionales que podrían haber sido emitidas incorrectamente. La dirección está trabajando con asesores legales para retirar adecuadamente las acciones, mientras se mantiene el enfoque operativo en iniciativas de salud y bienestar, incluyendo tratamientos con células madre de cordón umbilical y HSCT para la esclerosis múltiple.
ADIA Nutrition Inc. (OTC Pink: ADIA)는 약 10년 전에 적절한 문서 없이 발행되거나 약속된 약 2,500만 주의 문제를 발견했습니다. 여기에는 현재 유통 중인 1,500만 주와 현재 이사회가 취임하기 전에 지급 계약에서 약속된 1,000만 주가 포함됩니다. 회사는 이러한 주식을 퇴출할 계획이며, 이는 유통 주식 수를 약 15% 감소시킬 것입니다.
현재 주식 구조는 다음과 같습니다: 95,899,861 주식, 74,051,080 제한 주식, 21,848,781 비제한 주식, 19,575,347 DTC 보유 주식, 그리고 유통 주식 수 13,848,781. 회사는 잘못 발행되었을 수 있는 추가 제한 주식에 대해 조사하고 있습니다. 경영진은 건강 및 웰니스 이니셔티브, 특히 제대 혈액 줄기 세포 치료 및 다발성 경화증에 대한 HSCT의 운영 초점을 유지하면서 주식을 제대로 퇴출하기 위해 법률 자문과 함께 작업하고 있습니다.
ADIA Nutrition Inc. (OTC Pink: ADIA) a découvert des problèmes avec environ 25 millions d'actions émises ou engagées sans documentation appropriée il y a plus d'une décennie. Cela inclut 15 millions d'actions actuellement en circulation et 10 millions d'actions promises dans un accord de paiement avant le mandat actuel du conseil d'administration. La société prévoit de retirer ces actions, ce qui réduirait le nombre d'actions en circulation d'environ 15%.
La structure actuelle des actions indique : 95,899,861 actions en circulation, 74,051,080 actions restreintes, 21,848,781 actions non restreintes, 19,575,347 actions détenues au DTC, et une flottante de 13,848,781. L'entreprise enquête sur d'autres actions restreintes qui pourraient avoir été émises de manière inappropriée. La direction collabore avec des conseillers juridiques pour retirer correctement les actions tout en maintenant un accent opérationnel sur les initiatives de santé et de bien-être, y compris les traitements par cellules souches de cordon ombilical et la HSCT pour la sclérose en plaques.
ADIA Nutrition Inc. (OTC Pink: ADIA) hat Probleme mit etwa 25 Millionen Aktien entdeckt, die vor mehr als einem Jahrzehnt ohne entsprechende Dokumentation ausgegeben oder verpflichtet wurden. Dazu gehören 15 Millionen derzeit ausgegebene Aktien und 10 Millionen Aktien, die in einem Zahlungsvereinbarung vor der Amtszeit des aktuellen Vorstands zugesagt wurden. Das Unternehmen plant, diese Aktien zurückzuziehen, was die Anzahl der im Umlauf befindlichen Aktien um etwa 15 % verringern würde.
Die aktuelle Aktienstruktur zeigt: 95,899,861 ausgegebene Aktien, 74,051,080 eingeschränkte Aktien, 21,848,781 nicht eingeschränkte Aktien, 19,575,347 beim DTC gehaltene Aktien und einen Float von 13,848,781. Das Unternehmen untersucht zusätzliche eingeschränkte Aktien, die möglicherweise unrechtmäßig ausgegeben wurden. Das Management arbeitet mit rechtlichen Beratern zusammen, um die Aktien ordnungsgemäß zurückzuziehen, während der betriebliche Fokus auf Gesundheits- und Wellness-Initiativen, einschließlich Behandlungen mit Stammzellen aus der Nabelschnur und HSCT für Multiple Sklerose, aufrechterhalten wird.
- Planned 15% reduction in outstanding shares through share retirement
- Proactive approach to addressing historical share issuance issues
- Maintaining operational capabilities despite share structure cleanup
- Discovery of 25 million shares issued or committed without proper documentation
- Potential additional improper share issuances under investigation
- Historical compliance and documentation issues revealed
Winter Park, Florida--(Newsfile Corp. - February 11, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in health and wellness solutions, has uncovered issues with share issuance from over a decade ago. Following an internal review, it was discovered that around 25 million shares were either issued or committed without proper documentation. This includes 15 million shares currently outstanding and 10 million shares promised in an agreement to pay, prior to the current board's tenure. ADIA Nutrition is now actively working to retire these shares which would decrease the current number of outstanding shares by approximately 15 percent.
OTC Markets
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/239813_otcmarketsss.jpg
ADIA's Current Share Structure (as recorded by OTC Markets):
Outstanding: 95,899,861
Restricted: 74,051,080
Unrestricted: 21,848,781
Held at DTC: 19,575,347
Float: 13,848,781
The company's accountants and board are also examining other outstanding restricted shares that might have been improperly issued before the current board assumed control.
After a detailed review of its shareholder structure, ADIA Nutrition confirmed that these shares lacked the required legal documentation and regulatory filings.
Larry Powalisz, CEO of ADIA Nutrition Inc., commented, "We have taken immediate steps to correct this past oversight. Ensuring the integrity and legality of our share structure is crucial for our commitment to transparency. We are collaborating closely with our legal advisors to retire these shares appropriately."
Steps Being Taken Include:
Investigation: A comprehensive review of historical records to understand how the undocumented issuance occurred.
Compliance: Working with legal experts to ensure all share retirement complies with regulatory requirements.
Transparency: Engaging in direct communication with shareholders to keep them informed about the actions being taken.
This initiative will not impact ADIA Nutrition's operational capabilities or its strategic focus on health and wellness. The company continues its commitment to innovation in areas like umbilical cord stem cell treatments and Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Sclerosis.
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in Hematopoietic Stem Cell Transplantation (HSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adia-med.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239813
FAQ
How many shares will ADIA Nutrition (ADIA) retire from its share structure?
What is ADIA's current outstanding share count as of February 2025?
What percentage will ADIA's share retirement reduce its outstanding shares?
What steps is ADIA taking to address the share issuance issues?
What is ADIA's current float size according to the announcement?
